Definiens and Cenix BioScience expanded their mutual licensing agreement related to Cenix’ use of the Definiens’ technology. Resulting from the findings of an internal review, Definiens’ Cellenger® was reselected as the best available application to support Cenix in the development and implementation of high-content microscopy assays for HT-RNAi studies in cultured human and rodent cells, according to Cenix.

Cellenger enables the automated extraction of data from images used in cell-based assays. It allows Cenix to analyze structures of interest even in complex images with high accuracy, notes a Cenix spokesperson.

Next articleUMMZ Periodical Cicada Page